944 related articles for article (PubMed ID: 17032986)
1. Risk of myocardial infarction in patients with psoriasis.
Gelfand JM; Neimann AL; Shin DB; Wang X; Margolis DJ; Troxel AB
JAMA; 2006 Oct; 296(14):1735-41. PubMed ID: 17032986
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of myocardial infarction in patients with psoriasis in central China.
Xiao J; Chen LH; Tu YT; Deng XH; Tao J
J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1311-5. PubMed ID: 19522710
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of cardiovascular risk factors in patients with psoriasis.
Neimann AL; Shin DB; Wang X; Margolis DJ; Troxel AB; Gelfand JM
J Am Acad Dermatol; 2006 Nov; 55(5):829-35. PubMed ID: 17052489
[TBL] [Abstract][Full Text] [Related]
4. Risk of myocardial infarction in canadian patients with psoriasis: a retrospective cohort study.
Levesque A; Lachaine J; Bissonnette R
J Cutan Med Surg; 2013; 17(6):398-403. PubMed ID: 24138976
[TBL] [Abstract][Full Text] [Related]
5. Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study.
Ahlehoff O; Gislason GH; Lindhardsen J; Olesen JB; Charlot M; Skov L; Torp-Pedersen C; Hansen PR
J Intern Med; 2011 Sep; 270(3):237-44. PubMed ID: 21362070
[TBL] [Abstract][Full Text] [Related]
6. The risk of mortality in patients with psoriasis: results from a population-based study.
Gelfand JM; Troxel AB; Lewis JD; Kurd SK; Shin DB; Wang X; Margolis DJ; Strom BL
Arch Dermatol; 2007 Dec; 143(12):1493-9. PubMed ID: 18086997
[TBL] [Abstract][Full Text] [Related]
7. The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study.
Abuabara K; Lee H; Kimball AB
Br J Dermatol; 2011 Nov; 165(5):1066-73. PubMed ID: 21777216
[TBL] [Abstract][Full Text] [Related]
8. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis.
Brauchli YB; Jick SS; Miret M; Meier CR
Br J Dermatol; 2009 May; 160(5):1048-56. PubMed ID: 19210501
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis and risk of myocardial infarction before and during an era with biological therapy: a population-based follow-up study.
Leisner MZ; Lindorff Riis J; Gniadecki R; Iversen L; Olsen M
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2185-2190. PubMed ID: 29719939
[TBL] [Abstract][Full Text] [Related]
10. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis.
Kaye JA; Li L; Jick SS
Br J Dermatol; 2008 Sep; 159(4):895-902. PubMed ID: 18616778
[TBL] [Abstract][Full Text] [Related]
11. Association between the type and length of tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis.
Wu JJ; Poon KY; Bebchuk JD
J Drugs Dermatol; 2013 Aug; 12(8):899-903. PubMed ID: 23986163
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction.
Schuit SC; Oei HH; Witteman JC; Geurts van Kessel CH; van Meurs JB; Nijhuis RL; van Leeuwen JP; de Jong FH; Zillikens MC; Hofman A; Pols HA; Uitterlinden AG
JAMA; 2004 Jun; 291(24):2969-77. PubMed ID: 15213208
[TBL] [Abstract][Full Text] [Related]
13. Risk of myocardial infarction in psoriasis patients: a retrospective cohort study.
Wu JJ; Choi YM; Bebchuk JD
J Dermatolog Treat; 2015 Jun; 26(3):230-4. PubMed ID: 25102892
[TBL] [Abstract][Full Text] [Related]
14. Risk of Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Hidradenitis Suppurativa.
Egeberg A; Gislason GH; Hansen PR
JAMA Dermatol; 2016 Apr; 152(4):429-34. PubMed ID: 26885728
[TBL] [Abstract][Full Text] [Related]
15. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database.
Mehta NN; Azfar RS; Shin DB; Neimann AL; Troxel AB; Gelfand JM
Eur Heart J; 2010 Apr; 31(8):1000-6. PubMed ID: 20037179
[TBL] [Abstract][Full Text] [Related]
16. Risk of myocardial infarction among patients with gout: a nationwide population-based study.
Kuo CF; Yu KH; See LC; Chou IJ; Ko YS; Chang HC; Chiou MJ; Luo SF
Rheumatology (Oxford); 2013 Jan; 52(1):111-7. PubMed ID: 22787006
[TBL] [Abstract][Full Text] [Related]
17. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
[TBL] [Abstract][Full Text] [Related]
18. Do Biologics Protect Patients With Psoriasis From Myocardial Infarction? A Retrospective Cohort.
Gulliver WP; Randell S; Gulliver S; Connors S; Bachelez H; MacDonald D; Gladney N; Morrissey A; Fleming P
J Cutan Med Surg; 2016 Nov; 20(6):536-541. PubMed ID: 27207347
[TBL] [Abstract][Full Text] [Related]
19. Risk of Myocardial Infarction in Patients with Psoriasis and Psoriatic Arthritis: A Nationwide Cohort Study.
Egeberg A; Thyssen JP; Jensen P; Gislason GH; Skov L
Acta Derm Venereol; 2017 Jul; 97(7):819-824. PubMed ID: 28350413
[TBL] [Abstract][Full Text] [Related]
20. Do TNF inhibitors reduce the risk of myocardial infarction in psoriasis patients?
Armstrong AW
JAMA; 2013 May; 309(19):2043-4. PubMed ID: 23677316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
